Patent ID: 11921119
Assignee: MEMED DIAGNOSTICS LTD.
Field: Measurement (Instruments)
Classification: CPC G | IPC G

Claim 9:
10. The method of claim 1, further comprising measuring the level of at least one determinant selected from the group consisting of: C-reactive protein (CRP), procalcitonin (PCT), IP10, Interleukin 1 receptor type I, Serum amyloid A1, Triggering receptor expressed on myeloid cells 1, Triggering receptor expressed on myeloid cells 2, Radical S-adenosyl methionine domain containing 2, Lipocalin 2, Matrix metallopeptidase 8, MX Dynamin-Like GTPase 1, Calcitonin-related polypeptide alpha, Interleukin 6, 2-amino-6-(1,2,3-trihydroxypropyl)-1H-pteridin-4-one, Interleukin 2, Interleukin 7, and Interleukin 10.